Robot surgery may spare seminoma patients from chemo side effects
NCT ID NCT06144736
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This phase II trial is testing whether robot-assisted surgery to remove lymph nodes in the abdomen can help predict and prevent cancer recurrence in men with stage II seminoma. About 60 participants will undergo the procedure, with the option of one round of chemotherapy afterward. The goal is to reduce long-term side effects from standard treatments while keeping survival rates high.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Robot-assisted retroperitoneal lymph node dissection (surgery) and optional one cycle of cisplatin, etoposide, and bleomycin (chemotherapy)
What this could lead to
If successful, this approach could allow some men with seminoma to avoid long-term side effects of chemotherapy while maintaining high survival rates.
What could go wrong
This is a small, early-phase trial with only 60 participants, so results may not apply to everyone. Surgery carries risks like infection or nerve damage, and cancer may still return.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEMINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Duesseldorf
RECRUITINGDüsseldorf, Germany
Contact Email: •••••@•••••
Contact Email: •••••@•••••